A Study on the Preference of Risperidone Dosage Forms

NCT06657430 | Recruiting

• 1 other identifier: 2024-85
• Study Type: observational
• Target: 1,000
• Locations: 1 country
• Sites: 1

Brief Summary

This study aimed to understand patients' needs and preferences for antipsychotic dosage forms.

Conditions

Schizophrenia; Bipolar Affective Disorder; Autism Spectrum Disorder; Conduct Disorder; Mental Retardation

Keywords

risperidone; patch; cross-sectional study; preference

Outcome Measures

Primary Outcomes (1)

• Proportion of patients (and their caregivers) who prefer risperidone patch-form medicine

  The proportion of patients (and their caregivers) who preferred risperidone patch among the respondents in this study

  "through study completion, an average of 6 months

Secondary Outcomes (1)

• Factors related to patients' preference for risperidone patch-form medicines

  through study completion, an average of 6 months

Study Arms (1)

Patients and their caregivers

Patients (and their caregivers) with psychiatric disorders for which risperidone is indicated, including schizophrenia, bipolar disorder, autism spectrum disorder, conduct disorder, and mental retardation.

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.

You may qualify if:

• Patients with schizophrenia, bipolar disorder, autism spectrum disorder, mental retardation or their primary caregivers who voluntarily participate in the study.

You may not qualify if:

• Have difficulty reading and understanding Chinese or refuse to participate in the study.

Sponsors & Collaborators

• Shanghai Mental Health Center: lead

Study Sites (1)

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, 200030, China

RECRUITING

MeSH Terms

Conditions

Schizophrenia; Bipolar Disorder; Autism Spectrum Disorder; Conduct Disorder; Intellectual Disability

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic Disorders; Mental Disorders; Bipolar and Related Disorders; Mood Disorders; Child Development Disorders, Pervasive; Neurodevelopmental Disorders; Attention Deficit and Disruptive Behavior Disorders; Neurobehavioral Manifestations; Neurologic Manifestations; Nervous System Diseases; Signs and Symptoms; Pathological Conditions, Signs and Symptoms

Central Study Contacts

Lan Luo, Doctor of Medicine

CONTACT

+8618516544150; lan-luo@foxmail.com

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: CROSS SECTIONAL
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: October 21, 2024
• First Posted: October 24, 2024
• Study Start: September 19, 2024
• Primary Completion: February 28, 2025
• Study Completion: February 28, 2025
• Last Updated: October 24, 2024

Record last verified: 2024-09

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)